Hugh M. Cole, Chief Business Officer at Jounce Therapeutics, Inc. (JNCE), sold 18,000 shares at $11.95 ($215K) on 2021-01-22, disclosed to the SEC on 2021-01-25.
Open-market sale of $215k JNCE by Chief Business Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| JNCE | SELL | 2021-01-11 | $43K | — | Filing → |
| JNCE | SELL | 2020-08-18 | $10K | — | Filing → |
| JNCE | SELL | 2020-01-10 | $20K | — | Filing → |